PMID: 9173679Apr 1, 1996Paper

Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
M Berg-CandolfiL Z Benet

Abstract

1. Cytochrome P4503A (CYP3A) expression was studied in a murine model of infection. Mice were infected with a cystogenic strain of Toxoplasma gondii and microsomes were prepared for liver homogenates and jejunum villus tip enterocytes on day 10 postinfection. Total cytochrome P450 (CYP) and CYP3A were quantitated, and CYP3A activity was determined. 2. In the infected mouse, total CYP and CYP3A contents fell in the liver (-39 and - 49% respectively) and intestine (-43 and - 48 % respectively), as did the rate of metabolism of erythromycin (Ery) and cyclosporine A (CyA), two markers of CYP3A activity (-36 and -26% in the liver, -35 and -58% in the intestine). 3. To determine the mechanism(s) involved in the depression of hepatic CYP3A, infected mice were treated on day 7.5 post-infection with a monoclonal antibody raised against interferon-gamma (anti-IFN-gamma, or from days 7.5 to 10 post-infection with either N(G)-monomethyl-L-arginine (NMMA), an inhibitor of reactive nitrogen intermediates (RNI) production, or N-acetylcysteine (NAC), a reactive oxygen intermediates (ROI) scavenger. 4. Total CYP content was restored in the liver of infected mice treated with anti-IFN-gamma, but with marked interindividual variability. NAC treat...Continue Reading

References

Nov 1, 1992·Archives of Biochemistry and Biophysics·H IschiropoulosJ S Beckman
Apr 6, 1992·Biochimica Et Biophysica Acta·T YanagimotoT Kamataki
Sep 16, 1992·Biochemical and Biophysical Research Communications·D A PetersonE K Weir
Nov 1, 1992·Archives of Biochemistry and Biophysics·J S BeckmanM Tsai
Nov 1, 1992·The Journal of Clinical Investigation·J C KolarsP B Watkins
Aug 1, 1991·Archives of Biochemistry and Biophysics·R RadiB A Freeman
Dec 31, 1991·Biochemical and Biophysical Research Communications·G M RubanyiL H Botelho
Apr 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R D CurranT R Billiar
Jan 1, 1991·Methods in Enzymology·M A Correia
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Nov 1, 1990·Seminars in Liver Disease·P B Watkins
Jan 1, 1990·European Journal of Clinical Pharmacology·N InotsumeH Matsui
Nov 1, 1989·The Journal of Experimental Medicine·R D CurranR L Simmons
Sep 1, 1989·Biochemical Pharmacology·L M Bornheim, M A Correia
Nov 30, 1988·Biochemical and Biophysical Research Communications·J B HibbsE M Rachlin
Oct 1, 1987·The Journal of Clinical Investigation·P B WatkinsP S Guzelian
Jan 1, 1986·Respiration; International Review of Thoracic Diseases·P MoldéusM Berggren
Aug 1, 1969·Biochemistry·C R JefcoateR L Calabrese
Feb 29, 1984·Biochemical and Biophysical Research Communications·P GhezziM Salmona
Jan 1, 1983·Advances in Experimental Medicine and Biology·H W Murray
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·O G KhatsenkoJ R Vane
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A WinkJ B Mitchell
Jan 1, 1993·Archives of Biochemistry and Biophysics·D A WinkR W Nims

❮ Previous
Next ❯

Citations

Dec 5, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J H SchellensJ H Beijnen
Apr 25, 2000·Archives of Biochemistry and Biophysics·T SakumaN Nemoto
Sep 14, 2007·Journal of Pharmaceutical Sciences·Hiroshi Komura, Masahiro Iwaki
Jan 5, 2005·Journal of Hepatology·Yasuhiro MasubuchiToshiharu Horie
Oct 23, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Qing-Yu ZhangLaurence S Kaminsky
Aug 30, 2008·The Journal of Pharmacology and Experimental Therapeutics·Tomoe FujitaMasataka Majima
Nov 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Laurence S Kaminsky, Qing-Yu Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.